Suppr超能文献

血液癌症患者的治疗目标讨论:人与地点和时间与临终关怀利用的关系。

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.

机构信息

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Center for Lymphoma, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

出版信息

Cancer. 2020 Feb 1;126(3):515-522. doi: 10.1002/cncr.32549. Epub 2019 Oct 8.

Abstract

BACKGROUND

Patients with blood cancers experience high-intensity medical care near the end of life (EOL) and low rates of hospice use; attributes of goals of care (GOC) discussions may partly explain these outcomes.

METHODS

By using a retrospective cohort of patients with blood cancer who received care at Dana-Farber Cancer Institute and died in 2014, the authors assessed the potential relationship between timing, location, and the involvement of hematologic oncologists in the first GOC discussion with intensity of care near the EOL and timely hospice use.

RESULTS

Among 383 patients, 39.2% had leukemia/myelodysplastic syndromes, 37.1% had lymphoma, and 23.7% had myeloma. Overall, 65.3% of patients had a documented GOC discussion. Of the first discussions, 33.2% occurred >30 days before death, 34.8% occurred in the outpatient setting, and 46.4% included a hematologic oncologist. In multivariable analyses, having the first discussion >30 days before death (odds ratio [OR], 0.37; 95% CI, 0.17-0.81), in the outpatient setting (OR, 0.21; 95% CI, 0.09-0.50), and having a hematologic oncologist present (OR, 0.40; 95% CI, 0.21-0.77) were associated with lower odds of intensive care unit admission ≤30 days before death. The presence of a hematologic oncologist at the first discussion (OR, 3.07; 95% CI, 1.58-5.96) also was associated with earlier hospice use (>3 days before death).

CONCLUSIONS

In this large cohort of blood cancer decedents, most initial GOC discussions occurred close to death and in the inpatient setting. When discussions were timely, outpatient, or involved hematologic oncologists, patients were less likely to experience intensive health care use near death and were more likely to enroll in hospice.

摘要

背景

患有血液癌的患者在生命末期(EOL)接受高强度的医疗护理,但使用临终关怀的比例较低;目标关怀(GOC)讨论的属性可能部分解释了这些结果。

方法

通过使用在达纳-法伯癌症研究所接受治疗并于 2014 年去世的血液癌患者的回顾性队列,作者评估了首次 GOC 讨论的时间、地点和血液肿瘤学家的参与与 EOL 附近护理强度和及时使用临终关怀之间的潜在关系。

结果

在 383 名患者中,39.2%患有白血病/骨髓增生异常综合征,37.1%患有淋巴瘤,23.7%患有骨髓瘤。总体而言,65.3%的患者有记录的 GOC 讨论。在首次讨论中,33.2%发生在死亡前 30 天以上,34.8%发生在门诊,46.4%包括血液肿瘤学家。在多变量分析中,首次讨论发生在死亡前 30 天以上(比值比[OR],0.37;95%CI,0.17-0.81)、在门诊(OR,0.21;95%CI,0.09-0.50)和有血液肿瘤学家在场(OR,0.40;95%CI,0.21-0.77)与在死亡前 30 天内入住重症监护病房的可能性较低相关。首次讨论中有血液肿瘤学家(OR,3.07;95%CI,1.58-5.96)也与更早地使用临终关怀(>死亡前 3 天)相关。

结论

在这个大型血液癌死亡患者队列中,大多数初始 GOC 讨论发生在接近死亡和住院环境中。当讨论及时、门诊或涉及血液肿瘤学家时,患者在死亡前经历高强度医疗护理的可能性较低,并且更有可能接受临终关怀。

相似文献

2
Goals of care documentation by medical oncologists and oncology patient end-of-life care outcomes.
Cancer. 2022 Sep 15;128(18):3400-3407. doi: 10.1002/cncr.34400. Epub 2022 Jul 22.
3
End-of-life care for blood cancers: a series of focus groups with hematologic oncologists.
J Oncol Pract. 2014 Nov;10(6):e396-403. doi: 10.1200/JOP.2014.001537. Epub 2014 Oct 7.
4
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?
Curr Hematol Malig Rep. 2021 Apr;16(2):117-125. doi: 10.1007/s11899-021-00629-1. Epub 2021 Apr 16.
5
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23.
6
Actual and Missed Opportunities for End-of-Life Care Discussions With Oncology Patients: A Qualitative Study.
JAMA Netw Open. 2021 Jun 1;4(6):e2113193. doi: 10.1001/jamanetworkopen.2021.13193.
7
Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies.
J Palliat Med. 2022 Apr;25(4):556-561. doi: 10.1089/jpm.2021.0193. Epub 2021 Nov 25.
8
End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies.
Blood Adv. 2020 Aug 11;4(15):3606-3614. doi: 10.1182/bloodadvances.2020001767.
9
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
Gynecol Oncol. 2013 Jul;130(1):156-61. doi: 10.1016/j.ygyno.2013.04.010. Epub 2013 Apr 13.
10
Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient Mortality.
JCO Oncol Pract. 2023 Sep;19(9):767-776. doi: 10.1200/OP.23.00095. Epub 2023 Jun 30.

引用本文的文献

4
Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
JCO Oncol Pract. 2025 Jun;21(6):876-882. doi: 10.1200/OP-24-00556. Epub 2024 Dec 16.
5
Challenges in hospice and end-of-life care in the transfusion-dependent patient.
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):340-347. doi: 10.1182/hematology.2024000560.

本文引用的文献

1
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia.
Blood. 2018 Aug 16;132(7):717-726. doi: 10.1182/blood-2018-03-842575. Epub 2018 May 30.
2
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.
J Clin Oncol. 2017 Nov 1;35(31):3618-3632. doi: 10.1200/JCO.2017.75.2311. Epub 2017 Sep 11.
4
NCCN Guidelines Insights: Palliative Care, Version 2.2017.
J Natl Compr Canc Netw. 2017 Aug;15(8):989-997. doi: 10.6004/jnccn.2017.0132.
5
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life.
J Clin Oncol. 2017 Oct 20;35(30):3417-3424. doi: 10.1200/JCO.2017.72.7149. Epub 2017 Aug 7.
6
Challenge of Prognostic Uncertainty in the Modern Era of Cancer Therapeutics.
J Clin Oncol. 2016 Oct 20;34(30):3605-3608. doi: 10.1200/JCO.2016.67.8573.
7
Barriers to Quality End-of-Life Care for Patients With Blood Cancers.
J Clin Oncol. 2016 Sep 10;34(26):3126-32. doi: 10.1200/JCO.2016.67.8177. Epub 2016 Jul 11.
8
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
Cancer. 2016 Apr 15;122(8):1209-15. doi: 10.1002/cncr.29913. Epub 2016 Feb 23.
9
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.
JAMA Intern Med. 2016 Feb;176(2):263-5. doi: 10.1001/jamainternmed.2015.6599.
10
Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
J Natl Cancer Inst. 2015 Oct 5;108(1). doi: 10.1093/jnci/djv280. Print 2016 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验